It is very well established in animals that calorie restriction slows aging. There is no surprise here.
#semaglutideHD #glp1HD #miceHD #calorierestrictionHD #agingHD #longevityHD
A shared Nature study report says elderly female mice on semaglutide lived 12% longer and improved on aging hallmarks, matching or beating caloric restriction on several measures. Louis notes calorie restriction slowing aging in animals is well established. The caveats: inbred female mice, possible muscle loss in older people, and no human data.
It is very well established in animals that calorie restriction slows aging. There is no surprise here.
#semaglutideHD #glp1HD #miceHD #calorierestrictionHD #agingHD #longevityHD
Ozempic already reduces cardiovascular disease, kidney disease, liver disease, and neurodegenerative conditions. Scientists have struggled to explain why a drug designed to control blood sugar and appetite produces benefits across so many unrelated systems.
A new study in Nature suggests one answer: it may be slowing aging itself.
Elderly female mice given semaglutide lived 12 percent longer than controls, regained their curiosity and memory, and showed improvement across virtually every hallmark of aging, including inflammation, senescent cells, DNA damage, and brain cell growth. When compared directly to caloric restriction, the drug matched or outperformed it on several measures, without the hunger or metabolic adaptation that makes dieting so hard to sustain.
The caveats are significant. These are inbred female mice. Rapid weight loss can reduce lean muscle in older people, raising real concerns about frailty. Whether these results hold in humans remains an open and genuinely important question.
But two researchers at the National Institute on Aging put the finding plainly: rather than explaining GLP-1's benefits one disease at a time, the results suggest they share a common cause. Slowed aging.
Read the full story, link in comments.